These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35249786)
21. Immunohistochemical evaluation of galectin-3 expression in oral squamous cell carcinoma, oral leukoplakia and normal mucosa. Selvaraj FM; Joseph AP; Varun BR; Mony V; Siva Kumar TT Indian J Dent Res; 2022; 33(3):282-286. PubMed ID: 36656189 [TBL] [Abstract][Full Text] [Related]
22. Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma. Lombardi N; Varoni EM; Franchini R; Lodi G BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967933 [TBL] [Abstract][Full Text] [Related]
23. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study. Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769 [TBL] [Abstract][Full Text] [Related]
25. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway. Liu W; Yao Y; Shi L; Tang G; Wu L J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929 [TBL] [Abstract][Full Text] [Related]
26. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma. Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. Varun BR; Ranganathan K; Rao UK; Joshua E J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093 [TBL] [Abstract][Full Text] [Related]
28. Malignant transformation of oral proliferative verrucous leukoplakia: a series of 48 patients with suggestions for management. Favia G; Capodiferro S; Limongelli L; Tempesta A; Maiorano E Int J Oral Maxillofac Surg; 2021 Jan; 50(1):14-20. PubMed ID: 32586723 [TBL] [Abstract][Full Text] [Related]
29. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma. Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468 [TBL] [Abstract][Full Text] [Related]
30. Whole genome DNA methylation and mutational profiles identify novel changes in proliferative verrucous leukoplakia. Okoturo E; Green D; Clarke K; Liloglou T; Boyd MT; Shaw RJ; Risk JM Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jun; 135(6):893-903. PubMed ID: 37088660 [TBL] [Abstract][Full Text] [Related]
31. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study. Lan Q; Zhang C; Hua H; Hu X BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005 [TBL] [Abstract][Full Text] [Related]
32. Malignant transformation rate of oral leukoplakia in an Australian population. Shearston K; Fateh B; Tai S; Hove D; Farah CS J Oral Pathol Med; 2019 Aug; 48(7):530-537. PubMed ID: 31172563 [TBL] [Abstract][Full Text] [Related]
33. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review. Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571 [TBL] [Abstract][Full Text] [Related]
34. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients. Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630 [TBL] [Abstract][Full Text] [Related]
35. [The expression and clinical significance of Bmi-1 gene in oral leukoplakia with different prognosis]. Wu XB; Wang RY; Gong SR; Zhu J; Zhu S Zhonghua Yi Xue Za Zhi; 2022 Mar; 102(11):787-794. PubMed ID: 35325958 [No Abstract] [Full Text] [Related]
36. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Aguirre-Urizar JM; Lafuente-Ibáñez de Mendoza I; Warnakulasuriya S Oral Dis; 2021 Nov; 27(8):1881-1895. PubMed ID: 33606345 [TBL] [Abstract][Full Text] [Related]
37. The profile of chronic hyperplastic candidiasis: a clinico-pathological study. Winocur-Arias O; Zlotogorski-Hurvitz A; Ben-Zvi Y; Chaushu G; Edel J; Vered M; Kaplan I Virchows Arch; 2023 Oct; 483(4):527-534. PubMed ID: 37615705 [TBL] [Abstract][Full Text] [Related]
38. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia. Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275 [TBL] [Abstract][Full Text] [Related]
39. An anatomical perspective on clinicopathological characteristics and treatment outcomes of dorsal and ventrolateral tongue leukoplakia after carbon dioxide laser surgery. Yang SW; Lee YS; Chang LC; Yang CH; Luo CM BMC Oral Health; 2021 Jan; 21(1):45. PubMed ID: 33509189 [TBL] [Abstract][Full Text] [Related]